Table of contents

Inflammatory bowel disease

• Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis (11 October, 2004)

  A Sturm, A Z A Leite, S Danese, K A Krivacic, G A West, S Mohr, J W Jacobberger, C Fiocchi
• Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn’s disease (11 October, 2004)

  J Doering, B Begue, M J Lentze, F Rieux-Laucat, O Goulet, J Schmitz, N Cerf-Bensussan, F M Ruemmele
• A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease (11 October, 2004)

  A P Kennedy, E Nelson, D Reeves, G Richardson, C Roberts, A Robinson, A E Rogers, M Sculpher, D G Thompson
• A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis (11 October, 2004)

  S J H van Deventer, J A Tami, M K Wedel
• Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy

  (11 October, 2004)

  F Parente, S Greco, M Molteni, A Anderloni, G M Sampietro, P G Danelli, R Bianco, S Gallus, G Bianchi Porro
• NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression (11 October, 2004)

  J Wehkamp, J Harder, M Weichenthal, M Schwab, E Schäffeler, M Schlee, K R Herrlinger, A Stallmach, F Noack, P Fritz, J M Schröder, C L Bevins, K Fellermann, E F Stange